NORTHAMPTON, MA / ACCESS Newswire / April 1, 2025 / In 2006, Tomas Cihlar knew all too well that despite initial successes ...

A molecule that is currently being used to treat cancerous soft-tissue sarcomas may be the key for developing a cure for HIV. This molecule, known as EBC-46, works by temporarily activating the HIV ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human immunodeficiency virus (HIV) hides dormant inside of cells shrinks when ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

About 640 000 children have been orphaned by the virus. Picture: AFP Health advocacy groups have welcomed the HIV-Aids clinical trial showing HIV patients can control the virus without using ...

About 13% of people who have HIV don’t know they have it — one driver of the virus’ continuing spread. Ending AIDS in the United States by 2030 was one of President Donald Trump’s stated ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

could help stop the spread of HIV, since those who are virally suppressed cannot transmit the virus. And it's a game changer for patients who have trouble maintaining a regimen that requires ...